Be a Smart Investor
Monday, September 24, 2018
Amarin Corp. (AMRN) Has Soared To A New High On Study Results
Amarin Corp. (AMRN) announced Monday morning that the Vascepa cardiovascular or CV outcomes trial, REDUCE-IT, met its primary endpoint.
from RTT - Hot Stocks https://ift.tt/2MWkpm4
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment